Breaking News

Sartorius Stedim Biotech Expands PAT Portfolio

February 27, 2013

Adds single-use sensor technology with Aber partnership

Sartorius Stedim Biotech (SSB) has entered into a global sales and development partnership with Aber Instruments, a specialized supplier of sensor technology for in-line biomass measurement in cell cultivation and fermentation processes.
SSB has exclusive global marketing and distribution rights to Aber’s single-use sensor technology, and Aber will supply measuring instruments. SSB will manufacture the biomass sensors under license and integrate them into its single-use bioreactors. SSB will exclusively market these products in a dual-branding arrangement.
“Single-use sensors make our disposable bags even more intelligent,” said Stefan Schlack, senior vice president of marketing at SSB. “They deliver real-time information about the progress of cell culture processes and help biopharmaceutical customers to understand their processes even better and further optimize them — a decisive competitive advantage.”
Dr. John Carvell, sales and marketing director at Aber Instruments, said, “Based on SSB’s global sales and distribution network, we can make our technology accessible to an even wider group of customers. SSB has in-depth expertise in single-use technology and is thoroughly versed in bioprocesses. Together with our profound knowledge of in-line biomass measurement, both companies stand to benefit from the joint development of new sensors.”
blog comments powered by Disqus
  • The Role of Value in Drug Pricing

    The Role of Value in Drug Pricing

    Keren Shani, Ryan Million, Trinity Partners ||October 11, 2016
    Exploring the trend of using frameworks and models to evaluate the value of a drug

  • CRO-Sponsor Partnerships

    CRO-Sponsor Partnerships

    Craig Morgan, Brand Development Director, goBalto Inc.||October 11, 2016
    10 tips for enabling better CRO and sponsor collaborations

  • The Human Parts of Mouse Models

    The Human Parts of Mouse Models

    Julia Schueler, Head of in vivo Operations, Oncotest, a Charles River company ||October 11, 2016
    The PDX model system has come back into focus